Sulcal morphology in Alzheimer's disease: an effective marker of diagnosis and cognition.

Alzheimer's disease Cortical thickness Data-driven science Sulcal morphology Sulcal width

Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
12 2019
Historique:
received: 25 10 2018
revised: 23 07 2019
accepted: 24 07 2019
pubmed: 7 9 2019
medline: 7 8 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

Measuring the morphology of brain sulci has been recently proposed as a novel imaging approach in Alzheimer's disease (AD). We aimed to investigate the relevance of such an approach in AD, by exploring its (1) clinical relevance in comparison with traditional imaging methods, (2) relationship with amyloid deposition, (3) association with cognitive functions. Here, 51 patients (n = 32 mild cognitive impairment/mild dementia-AD, n = 19 moderate/severe dementia-AD) diagnosed according to clinical-biological criteria (CSF biomarkers and amyloid-PET) and 29 controls (with negative amyloid-PET) underwent neuropsychological and 3T-MRI examinations. Mean sulcal width (SW) and mean cortical thickness around the sulcus (CT-S) were automatically measured. We found higher SW and lower CT-S in patients with AD than in controls. These differences were more pronounced at later stages of the disease and provided the best diagnostic accuracies among the imaging markers. Correlations were not found between CT-S or SW and amyloid deposition but between specific cognitive functions and regional CT-S/SW in key associated regions. Sulcal morphology is a good supporting diagnosis tool that reflects the main cognitive impairments in AD. It could be considered as a good surrogate marker to evaluate the efficacy of new drugs.

Identifiants

pubmed: 31491594
pii: S0197-4580(19)30219-2
doi: 10.1016/j.neurobiolaging.2019.07.015
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-49

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Maxime Bertoux (M)

Univ Lille, Inserm, CHU Lille, UMR 1171, Degenerative and Vascular Cognitive Disorders, Lille, France; Unit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, Centre Hospitalier Sainte Anne, Paris, France. Electronic address: maxime.bertoux@inserm.fr.

Julien Lagarde (J)

Unit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, Centre Hospitalier Sainte Anne, Paris, France; UMR 1023 IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.

Fabian Corlier (F)

Imaging Genetics Center, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, USA.

Lorraine Hamelin (L)

Unit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, Centre Hospitalier Sainte Anne, Paris, France; UMR 1023 IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.

Jean-François Mangin (JF)

Neurospin, CEA, Gif-sur-Yvette, France.

Olivier Colliot (O)

Institut du Cerveau et de la Moelle épinière, ICM, Inserm, Sorbonne Universités, UPMC Univ Paris 06, Paris, France.

Marie Chupin (M)

Institut du Cerveau et de la Moelle épinière, ICM, Inserm, Sorbonne Universités, UPMC Univ Paris 06, Paris, France.

Meredith N Braskie (MN)

Imaging Genetics Center, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, USA.

Paul M Thompson (PM)

Imaging Genetics Center, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, USA.

Michel Bottlaender (M)

UMR 1023 IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France; Neurospin, CEA, Gif-sur-Yvette, France.

Marie Sarazin (M)

Unit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, Centre Hospitalier Sainte Anne, Paris, France; UMR 1023 IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.

Articles similaires

1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature
alpha-Synuclein Humans Animals Mice Lewy Body Disease
Alzheimer Disease Humans Regression Analysis Quantitative Structure-Activity Relationship Drug Design
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH